Epidemiologic aspects of neural tube defects in South East Iran

Neurosciences

Volumn 11, Issue 4, 2006, Pages 289-292

  Afshar, Mohammad ^a   Golalipour, Mohammad J ^b   Farhud, Dariush ^c  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANENCEPHALUS; ARTICLE; CONSANGUINEOUS MARRIAGE; DISEASE PREDISPOSITION; DRUG USE; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; NEURAL TUBE DEFECT; NEWBORN; SEASONAL VARIATION; SEX DIFFERENCE; SPINA BIFIDA;

EID: 33846000970     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario 1986-1999. CMAJ 2002; 167: 237-240.
2. Copp AJ, Brook FA, Estibeiro JP, Shum AS, Cockroft DL. The embryonic development of mammalian neural tube defects. Prog Neurobiol 1990; 35: 363-403.
3. Nau H. Valproic acid - induced neural tube defects. In: Bock G, Marsh J, editors. Neural tube defects. Chichester (UK): John Wiley & Sons Ltd; 1994. p. 144-160.
4. Warkany J. Aminopterin and methotrexate: folic acid deficiency. Teratology 1978; 17: 353-358.
5. Shaw EB. Fetal damage due to maternal aminopterin ingestion. Am J Dis Child 1972; 124: 93-94.
6. Holmes LB. Spina bifida: anticonvulsants and other maternal influences. In: Bock G, Marsh J, editors. Neural tube defects. Chichester (UK): John Wiley & Sons Ltd; 1994. p. 332-338.
7. Mills JL, Baker L, Goldman S. Malformations in infants of diabetic mothers occurs before the seventh gestational week. Diabetes 1979; 28: 292-293.
8. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. Oxford (UK): Oxford University Press; 1992.
9. Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jick H. Maternal heat exposure and neural tube defects. JAMA 1992; 268: 882-885.
10. Botto LD, Yang A. Methylene tetrahydrofolate reductase (MTHFR) and birth defects. Am J Epidemiol 2000; 151: 862-877.
11. Tuncbilek E, Boduroglo K, Alikasifoglu M. Neural tube defects in Turkey prevalence distribution and risk factors. Turk J Pediatrics 1999; 41: 299-305.
12. van der Put NM, Steegers-Theunissen RPM, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
13. De-Wals P, Trochet C, Pinsonneavlt L. Prevalence of neural tube defect in the province of Quebec. Can J Public Health 1999; 90: 237-239.
14. Buccimazza SS, Molteno CD, Dunne TT, Viljoen DL. Prevalence of neural tube defects in Cape Town, South Africa. Teratology 1994; 50: 194-199.
15. Teixira AL, Loreto H, Machado MD. Neural tube defect the 10-years experience of a central maternity hospital. Acta Med Port 1994; 7: 419-425.
16. Koch M, Fuhrmann W. Epidemiology of neural tube defects in Germany. Hum Genet 1984; 68: 97-103.
17. Rankin J, Glinianaia S, Brown R, Renwick M. The changing prevalence of neural tube defects: A population - based study in the north of England, 1984-96. [Northern congenital Abnormality Survey steering Group.] Paediatr Perinat Epidemiol 2000; 14: 104-110.
18. Alembik Y, Dott B, Roth MP, Stoll C. Prevalence of neural tube defects in northeastern France, 1979-1992 impact of prenatal diagnosis. Ann Genet 1995; 38: 49-53.
19. Hendricks KA, Simpson JS, Larsen RD. Neural Tube defect along the Texas, Mexico border. Am J Epidemiol 1999; 149: 1119-1127.
20. Moore CA, Li S, Li Z, Hong SX, Gu HQ, Berry RJ, et al. Elevated rates of severe neural tube defects in a high prevalence area in northern china. Am J Med Genet 1997; 73: 113-118.
21. Tuncbilek E, Boduroglu K, Alikasifoglu M. Neural Tube defect in Turkey. Prevalence, Distribution and risk factor. Turk J Pediatr 1999; 41: 299-305.
22. Golalipour MJ, Vakili MA, Arya B. Neural tube defects in newborns in the south-east of the Caspian sea border (Gorgan, IRAN 1998-2000). Medical Journal of the Islamic Republic of Iran 2003; 16: 199-203.
23. Farhud DD, Hadavi V, Sadeghi H. Epidemiology of neural tube defects in the world and Iran. Iran J Public Health 2000; 29: 83-90.
24. Stoll C, Dotl B, Roth MP, Alembik Y. Etiologic and epidemiologic aspects of neural tube defect. Arch Fr Pediatr 1988; 45: 617-622.
25. Van Allen MI, Kalousek DK, Chernoff GF, Juriloff D, Harris M, McGillivray BC, et al. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 1993; 47: 723-743.
26. Dolk H, De Wals P, Gillerot Y, Lechat MF, Ayme S, Cornel M, et al. Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology 1991; 44: 541-559.
27. Ncayiyana DJ. Neural tube defects among rural blacks in a Transkei district. S Afr Med J 1986; 69: 618-620.
28. Lynberg MC, Khoury MJ. Contribution of birth defects to infant mortality among racial/ethnic minority groups, United States, 1983. MMWR CDC Surveill Summ 1990; 39: 1-12.
29. Murshid WR. Spina bifida in Saudi Arabia: is consanguinity among the parents a risk factor? Pediatr Neurosurg 2000; 32: 10-12.
30. McDonnell RJ, Johnson Z, Delaney V, Dack P. East Ireland 1980-1994: epidemiology of neural tube defects. J Epidemiol Community Health 1999; 53: 782-788.
31. Buccimazza SS, Molteno CD, Dunne TT, Viljoen DL. Prevalence of neural tube defects in Cape Town, South Africa. Teratology 1994; 50: 194-199.
32. Strassburg MA, Greenland S, Portigal LD, Sever LE. A population - based case control study of anencephalus and spina bifida in a low - risk area. Dev Med Child Neurol 1983; 25: 632-641.
33. Bound JP, Francis BJ, Harvey PW. Neural Tube Defects Maternal Cohorts and age. A pointer to aetiology. Arch Dis Child 1991; 66: 1223-1226.
34. Janerich DT. Epidemic Waves in the Prevalence of Anencephaly and Spinabifida in NY State. Teratology 1973; 8: 253-256.
35. Little J, Elwood JM. Epidemiology of neural Tube Defects. IV. Migrants and their descendants. In: Kiely M, editor. Reproductive and Perinatal epidemiology. Boca Raton (FL): CRC Press Inc; 1991.
36. Canfield AM, Anderson LJ, Waller DK, Palmer ES, Kaye IC. Folic acid awareness and use among woman with a history of a neural tube defect pregnancy- Texas 2000-2001. MMWR 2002; 51: 16-19.
37. Kirke P, Daly L, Elwood J. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child 1992; 67: 1442-1446.
38. Gupta H, Gupta P. Neural tube defects and folic acid. Indian Pediatr 2004; 41: 577-586.